Advanced search
Publication Cover
Cancer Management and Research Volume 14, 2022 - Issue
Submit an article Journal homepage
325
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data

Hikmat Abdel-Razeq1 Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan;2 Department of Internal Medicine, School of Medicine, The University of Jordan, Amman, JordanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2833-6051View further author information
ORCID Icon,
Baha’ Sharaf1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanORCID Iconhttps://orcid.org/0000-0003-4368-1224View further author information
ORCID Icon,
Rama AlMasri3 Department of Internal Medicine, Istishari Hospital, Amman, JordanView further author information
,
Rashid Abdel-Razeq1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanView further author information
,
Faris Tamimi1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanView further author information
,
Omar Khader1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanView further author information
,
Osama Salama1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanView further author information
,
Mahmoud Abunasser1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanORCID Iconhttps://orcid.org/0000-0002-8682-227XView further author information
ORCID Icon,
Sarah Edaily1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanView further author information
&
Hazem Abdulelah1 Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanView further author information
 show all
Pages 1033-1041 | Published online: 08 Mar 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Siyuan Gao, Yu Li, Zhichao He, Jianhong Zhu, Dan Liang, Shan Yang, Jiayao Mo, Kakei Lam, Xiaoxia Yu, Ming Huang & Junyan Wu. (2023) Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review. Expert Opinion on Drug Safety 22:7, pages 599-609.
Read now

Articles from other publishers (3)

Nathan W. Watson, Joseph J. Shatzel & Hanny Al-Samkari. (2023) Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidence. Journal of Thrombosis and Haemostasis 21:4, pages 758-770.
Crossref
. (2023) Fulvestrant/letrozole/ribociclib. Reactions Weekly 1939:1, pages 223-223.
Crossref
Aaron T. Jacobs, Diana Martinez Castaneda-Cruz, Mark M. Rose & Linda Connelly. (2022) Targeted therapy for breast cancer: An overview of drug classes and outcomes. Biochemical Pharmacology 204, pages 115209.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.